Page last updated: 2024-11-04

tetracaine and Drug Hypersensitivity

tetracaine has been researched along with Drug Hypersensitivity in 20 studies

Tetracaine: A potent local anesthetic of the ester type used for surface and spinal anesthesia.
tetracaine : A benzoate ester in which 4-N-butylbenzoic acid and 2-(dimethylamino)ethanol have combined to form the ester bond; a local ester anaesthetic (ester caine) used for surface and spinal anaesthesia.

Drug Hypersensitivity: Immunologically mediated adverse reactions to medicinal substances used legally or illegally.

Research

Studies (20)

Timeframe	Studies, this research(%)	All Research%
pre-1990	18 (90.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (5.00)	29.6817
2010's	1 (5.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
García-Gavín, J	1
Alonso-González, J	1
Gutiérrez-González, E	1
Álvarez-Pérez, A	1
Fernández-Redondo, V	1
Toribio, J	1
Cox, B	1
Durieux, ME	1
Marcus, MA	1
RICCHETTI, C	1
CRISCI, J	1
Johnson, WT	1
DeStigter, T	1
Crowhust, JA	1
Norden, LC	1
Kreilgård, B	1
Hansen, J	1
Fischer, T	1
Beck, MH	1
Holden, A	1
Sehhati, G	1
Frey, R	1
Mildner, R	1
Brown, LL	1
Covino, BG	1
Judit, BS	1
von Maur, K	1
Rocklin, RE	1
Stevens, MB	1
Oelschläger, H	1
Nieschulz, O	1
Meyer, F	1
Schulz, KH	1
Kahn, G	1
Aldrete, JA	2
Ryan, SC	1
O'Higgins, JW	1
Hornbostel, H	1
Kirilov, S	1
Ganov, B	1
Vuzelov, S	1
Dushepeev, Kh	1
Lozev, R	1
Salupere, VP	1
Koch, SA	1
Rubin, LF	1

Clinical Trials (3)

Trial Overview

Trial	Enrollment	Study Type	Start Date	Status
Clinical Evaluation of Arrhythmia Mapping With a Globe-Shaped, High-Density, Multi-Electrode Mapping Catheter[NCT05373862]	40 participants (Actual)	Interventional	2022-07-29	Completed
Clinical Evaluation of Arrhythmia Mapping With the Multi-Electrode OPTRELL™ Mapping Catheter[NCT04983797]	31 participants (Actual)	Interventional	2021-08-25	Completed
Clinical Evaluation of Intracardiac Ultrasound With the NUVISION NAV Ultrasound Catheter[NCT05970120]	30 participants (Anticipated)	Interventional	2023-09-05	Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial Outcomes

Number of Participants With Non-serious Adverse Events Within 7 Days of Index Procedure Associated With the Use of the OPTRELL Catheter

Number of participants with non-serious adverse events within 7 days of index procedure associated with the use of the OPTRELL catheter were reported. An AE is any untoward medical occurrence in a participant participating in a clinical study that does not necessarily have a causal relationship with the pharmaceutical/biological agent under study. (NCT04983797)
Timeframe: Up to 7 days of index procedure at Day 0

Intervention	Participants (Count of Participants)
OPTRELL Mapping Catheter	0

Number of Participants With Pre-ablation Mapping and Clinically Indicated Mapping Performed With the OPTRELL Catheter Without Resort to Other Mapping Catheters

Number of participants with pre-ablation mapping and clinically indicated mapping performed with the OPTRELL catheter without resort to other mapping catheters were reported. (NCT04983797)
Timeframe: Up to 72 days

Intervention	Participants (Count of Participants)
OPTRELL Mapping Catheter	31

Number of Participants With SAEs Within 7 Days of Index Procedure

Number of participants with SAEs within 7 days of index procedure were reported. An AE is any untoward medical occurrence in a participant whether or not related to the investigational device. SAE is any AE that results in: death, persistent or significant disability/incapacity, requires inpatient hospitalization or prolongation of existing hospitalization, is life-threatening experience, is a congenital anomaly/birth defect and may jeopardize participant and/or may require medical or surgical intervention to prevent one of the outcomes listed above. (NCT04983797)
Timeframe: Up to 7 days of index procedure at Day 0

Intervention	Participants (Count of Participants)
OPTRELL Mapping Catheter	3

Number of Participants With Serious Adverse Events (SAEs) Within 7 Days of Index Procedure Related to the OPTRELL Catheter

Number of participants with SAEs within 7 days of index procedure related to the OPTRELL catheter were reported. An adverse event (AE) is any untoward medical occurrence in a participant whether or not related to the investigational device. SAE is any AE that results in: death, persistent or significant disability/incapacity, requires inpatient hospitalization or prolongation of existing hospitalization, is life-threatening experience, is a congenital anomaly/birth defect and may jeopardize participant and/or may require medical or surgical intervention to prevent one of the outcomes listed above. (NCT04983797)
Timeframe: Up to 7 days of index procedure at Day 0

Intervention	Participants (Count of Participants)
OPTRELL Mapping Catheter	0

Number of Responders for Physician Assessment for Ability to Characterize the Tissue

Number of responders for physician assessment for ability to characterize the tissue were reported. A post-procedure survey of 11 questions, each with individual sub-questions were asked. Each question/sub-question was answered by the physician using a Likert scale of 1 to 7 (1=poor and 7=excellent). Responders refers to participants with physician assessment for ability to characterize the tissue. (NCT04983797)
Timeframe: Up to 72 days

Intervention	Participants (Count of Participants)
	Compared to the PENTARAY catheter?: Score 1	Compared to the PENTARAY catheter?: Score 2	Compared to the PENTARAY catheter?: Score 3	Compared to the PENTARAY catheter?: Score 4	Compared to the PENTARAY catheter?: Score 5	Compared to the PENTARAY catheter?: Score 6	Compared to the PENTARAY catheter?: Score 7	Compared to other competitive multielectrode catheters?: Score 1	Compared to other competitive multielectrode catheters?: Score 2	Compared to other competitive multielectrode catheters?: Score 3	Compared to other competitive multielectrode catheters?: Score 4	Compared to other competitive multielectrode catheters?: Score 5	Compared to other competitive multielectrode catheters?: Score 6	Compared to other competitive multielectrode catheters?: Score 7
OPTRELL Mapping Catheter	0	0	0	0	0	16	15	0	0	0	0	0	25	0

Number of Responders for Physician Assessment for Arrhythmogenicity

Number of responders with physician assessment for arrhythmogenicity were reported. A post-procedure survey of 11 questions, each with individual sub-questions were asked. Each question/sub-question was answered by the physician using a Likert scale of 1 to 7 (1=poor and 7=excellent). Responders refers to participants with physician assessment for arrhythmogenicity. (NCT04983797)
Timeframe: Up to 72 days

Intervention	Participants (Count of Participants)
	Compared to the PENTARAY catheter?: Score 1	Compared to the PENTARAY catheter?: Score 2	Compared to the PENTARAY catheter?: Score 3	Compared to the PENTARAY catheter?: Score 4	Compared to the PENTARAY catheter?: Score 5	Compared to the PENTARAY catheter?: Score 6	Compared to the PENTARAY catheter?: Score 7	Compared to other competitive multielectrode catheters?: Score 1	Compared to other competitive multielectrode catheters?: Score 2	Compared to other competitive multielectrode catheters?: Score 3	Compared to other competitive multielectrode catheters?: Score 4	Compared to other competitive multielectrode catheters?: Score 5	Compared to other competitive multielectrode catheters?: Score 6	Compared to other competitive multielectrode catheters?: Score 7
OPTRELL Mapping Catheter	0	0	0	2	5	10	14	0	0	0	0	5	19	1

Number of Responders for Physician Assessment for Catheter Design in OPTRELL Catheter for Mapping

Number of responders for physician assessment for catheter design were reported. A post-procedure survey of 11 questions, each with individual sub-questions were asked. Each question/sub-question was answered by the physician using a Likert scale of 1 to 7 (1=poor and 7=excellent). Responders refers to participants with physician assessment for catheter design in OPTRELL catheter for mapping. (NCT04983797)
Timeframe: Up to 72 days

Intervention	Participants (Count of Participants)
	Ability to achieve electrode contact with cardiac tissue: Score 1	Ability to achieve electrode contact with cardiac tissue: Score 2	Ability to achieve electrode contact with cardiac tissue: Score 3	Ability to achieve electrode contact with cardiac tissue: Score 4	Ability to achieve electrode contact with cardiac tissue: Score 5	Ability to achieve electrode contact with cardiac tissue: Score 6	Ability to achieve electrode contact with cardiac tissue: Score 7	Electrodes spacing: Score 1	Electrodes spacing: Score 2	Electrodes spacing: Score 3	Electrodes spacing: Score 4	Electrodes spacing: Score 5	Electrodes spacing: Score 6	Electrodes spacing: Score 7	Electrode array coverage: Score 1	Electrode array coverage: Score 2	Electrode array coverage: Score 3	Electrode array coverage: Score 4	Electrode array coverage: Score 5	Electrode array coverage: Score 6	Electrode array coverage: Score 7
OPTRELL Mapping Catheter	0	1	0	2	2	18	8	0	1	0	0	0	13	17	0	1	0	0	0	9	21

Number of Responders for Physician Assessment for Catheter Visualization

Number of responders for physician assessment for catheter visualization were reported. A post-procedure survey of 11 questions, each with individual sub-questions were asked. Each question/sub-question was answered by the physician using a Likert scale of 1 to 7 (1=poor and 7=excellent). Responders refers to participants with physician assessment for catheter visualization. (NCT04983797)
Timeframe: Up to 72 days

Intervention	Participants (Count of Participants)
	Visualization under fluoroscopy: Score 1	Visualization under fluoroscopy: Score 2	Visualization under fluoroscopy: Score 3	Visualization under fluoroscopy: Score 4	Visualization under fluoroscopy: Score 5	Visualization under fluoroscopy: Score 6	Visualization under fluoroscopy: Score 7	Visualization in CARTO 3: Score 1	Visualization in CARTO 3: Score 2	Visualization in CARTO 3: Score 3	Visualization in CARTO 3: Score 4	Visualization in CARTO 3: Score 5	Visualization in CARTO 3: Score 6	Visualization in CARTO 3: Score 7
OPTRELL Mapping Catheter	0	0	0	0	7	9	15	0	0	0	0	3	10	18

Number of Responders for Physician Assessment for Catheters Interactions

Number of responders for physician assessment for catheters interactions were reported. A post-procedure survey of 11 questions, each with individual sub-questions were asked. Each question/sub-question was answered by the physician using a Likert scale of 1 to 7 (1=poor and 7=excellent). Responders refers to participants with physician assessment for catheters interactions. (NCT04983797)
Timeframe: Up to 72 days

Intervention	Participants (Count of Participants)
	With CARTO 3 System: Score 1	With CARTO 3 System: Score 2	With CARTO 3 System: Score 3	With CARTO 3 System: Score 4	With CARTO 3 System: Score 5	With CARTO 3 System: Score 6	With CARTO 3 System: Score 7	EP Lab recording equipment: Score 1	EP Lab recording equipment: Score 2	EP Lab recording equipment: Score 3	EP Lab recording equipment: Score 4	EP Lab recording equipment: Score 5	EP Lab recording equipment: Score 6	EP Lab recording equipment: Score 7	Pacing equipment: Score 1	Pacing equipment: Score 2	Pacing equipment: Score 3	Pacing equipment: Score 4	Pacing equipment: Score 5	Pacing equipment: Score 6	Pacing equipment: Score 7	Introducer tool on catheter: Score 1	Introducer tool on catheter: Score 2	Introducer tool on catheter: Score 3	Introducer tool on catheter: Score 4	Introducer tool on catheter: Score 5	Introducer tool on catheter: Score 6	Introducer tool on catheter: Score 7	Sheath: Score 1	Sheath: Score 2	Sheath: Score 3	Sheath: Score 4	Sheath: Score 5	Sheath: Score 6	Sheath: Score 7	Irrigation bag and tubing: Score 1	Irrigation bag and tubing: Score 2	Irrigation bag and tubing: Score 3	Irrigation bag and tubing: Score 4	Irrigation bag and tubing: Score 5	Irrigation bag and tubing: Score 6	Irrigation bag and tubing: Score 7	ICD or other implantable devices: Score 1	ICD or other implantable devices: Score 2	ICD or other implantable devices: Score 3	ICD or other implantable devices: Score 4	ICD or other implantable devices: Score 5	ICD or other implantable devices: Score 6	ICD or other implantable devices: Score 7
OPTRELL Mapping Catheter	0	0	0	0	4	12	15	0	0	0	1	8	12	10	0	0	0	0	4	3	7	0	0	0	3	6	14	8	0	0	0	3	6	14	8	0	0	0	0	5	15	11	0	0	0	1	2	2	3

Number of Responders for Physician Assessment for Design and Coverage for Confirming PVI

Number of responders for physician assessment for design and coverage for confirming PVI were reported. A post-procedure survey of 11 questions, each with individual sub-questions were asked. Each question/sub-question was answered by the physician using a Likert scale of 1 to 7 (1=poor and 7=excellent). Responders refers to participants with physician assessment for design and coverage for confirming PVI. (NCT04983797)
Timeframe: Up to 72 days

Intervention	Participants (Count of Participants)
	Compared to the PENTARAY catheter?: Score 1	Compared to the PENTARAY catheter?: Score 2	Compared to the PENTARAY catheter?: Score 3	Compared to the PENTARAY catheter?: Score 4	Compared to the PENTARAY catheter?: Score 5	Compared to the PENTARAY catheter?: Score 6	Compared to the PENTARAY catheter?: Score 7	Compared to other competitive multielectrode catheters?: Score 1	Compared to other competitive multielectrode catheters?: Score 2	Compared to other competitive multielectrode catheters?: Score 3	Compared to other competitive multielectrode catheters?: Score 4	Compared to other competitive multielectrode catheters?: Score 5	Compared to other competitive multielectrode catheters?: Score 6	Compared to other competitive multielectrode catheters?: Score 7
OPTRELL Mapping Catheter	0	0	0	3	2	7	9	0	0	0	4	0	13	4

Number of Responders for Physician Assessment for Maneuverability & Handling

Number of responders for physician assessment for maneuverability & handling were reported. A post-procedure survey of 11 questions, each with individual sub-questions were asked. Each question/sub-question was answered by the physician using a Likert scale of 1 to 7 (1=poor and 7=excellent). Responders refers to participants with physician assessment for maneuverability & handling. (NCT04983797)
Timeframe: Up to 72 days

Intervention	Participants (Count of Participants)
	Ability to Deploy (Left Atrium): Score 1	Ability to Deploy (Left Atrium): Score 2	Ability to Deploy (Left Atrium): Score 3	Ability to Deploy (Left Atrium): Score 4	Ability to Deploy (Left Atrium): Score 5	Ability to Deploy (Left Atrium): Score 6	Ability to Deploy (Left Atrium): Score 7	Ability to Deploy (Right Atrium): Score 1	Ability to Deploy (Right Atrium): Score 2	Ability to Deploy (Right Atrium): Score 3	Ability to Deploy (Right Atrium): Score 4	Ability to Deploy (Right Atrium): Score 5	Ability to Deploy (Right Atrium): Score 6	Ability to Deploy (Right Atrium): Score 7	Ability to Deploy (Left Ventricle): Score 1	Ability to Deploy (Left Ventricle): Score 2	Ability to Deploy (Left Ventricle): Score 3	Ability to Deploy (Left Ventricle): Score 4	Ability to Deploy (Left Ventricle): Score 5	Ability to Deploy (Left Ventricle): Score 6	Ability to Deploy (Left Ventricle): Score 7	Ability to Deploy (Right Ventricle): Score 1	Ability to Deploy (Right Ventricle): Score 2	Ability to Deploy (Right Ventricle): Score 3	Ability to Deploy (Right Ventricle): Score 4	Ability to Deploy (Right Ventricle): Score 5	Ability to Deploy (Right Ventricle): Score 6	Ability to Deploy (Right Ventricle): Score 7	Ability to Maneuver (Left Atrium): Score 1	Ability to Maneuver (Left Atrium): Score 2	Ability to Maneuver (Left Atrium): Score 3	Ability to Maneuver (Left Atrium): Score 4	Ability to Maneuver (Left Atrium): Score 5	Ability to Maneuver (Left Atrium): Score 6	Ability to Maneuver (Left Atrium): Score 7	Ability to Maneuver (Right Atrium): Score 1	Ability to Maneuver (Right Atrium): Score 2	Ability to Maneuver (Right Atrium): Score 3	Ability to Maneuver (Right Atrium): Score 4	Ability to Maneuver (Right Atrium): Score 5	Ability to Maneuver (Right Atrium): Score 6	Ability to Maneuver (Right Atrium): Score 7	Ability to Maneuver (Left Ventricle): Score 1	Ability to Maneuver (Left Ventricle): Score 2	Ability to Maneuver (Left Ventricle): Score 3	Ability to Maneuver (Left Ventricle): Score 4	Ability to Maneuver (Left Ventricle): Score 5	Ability to Maneuver (Left Ventricle): Score 6	Ability to Maneuver (Left Ventricle): Score 7	Ability to Maneuver (Right Ventricle): Score 1	Ability to Maneuver (Right Ventricle): Score 2	Ability to Maneuver (Right Ventricle): Score 3	Ability to Maneuver (Right Ventricle): Score 4	Ability to Maneuver (Right Ventricles): Score 5	Ability to Maneuver (Right Ventricle): Score 6	Ability to Maneuver (Right Ventricle): Score 7	Ability to Reach Areas (Left Atrium): Score 1	Ability to Reach Areas (Left Atrium): Score 2	Ability to Reach Areas (Left Atrium): Score 3	Ability to Reach Areas (Left Atrium): Score 4	Ability to Reach Areas (Left Atrium): Score 5	Ability to Reach Areas (Left Atrium): Score 6	Ability to Reach Areas (Left Atrium): Score 7	Ability to Reach Areas (Right Atrium): Score 1	Ability to Reach Areas (Right Atrium): Score 2	Ability to Reach Areas (Right Atrium): Score 3	Ability to Reach Areas (Right Atrium): Score 4	Ability to Reach Areas (Right Atrium): Score 5	Ability to Reach Areas (Right Atrium): Score 6	Ability to Reach Areas (Right Atrium): Score 7	Ability to Reach Areas (Left Ventricle): Score 1	Ability to Reach Areas (Left Ventricle): Score 2	Ability to Reach Areas (Left Ventricle): Score 3	Ability to Reach Areas (Left Ventricle): Score 4	Ability to Reach Areas (Left Ventricle): Score 5	Ability to Reach Areas (Left Ventricle): Score 6	Ability to Reach Areas (Left Ventricle): Score 7	Ability to Reach Areas (Right Ventricle): Score 1	Ability to Reach Areas (Right Ventricle): Score 2	Ability to Reach Areas (Right Ventricle): Score 3	Ability to Reach Areas (Right Ventricle): Score 4	Ability to Reach Areas (Right Ventricle): Score 5	Ability to Reach Areas (Right Ventricle): Score 6	Ability to Reach Areas (Right Ventricle): Score 7	Ability to Withdraw (Left Atrium): Score 1	Ability to Withdraw (Left Atrium): Score 2	Ability to Withdraw (Left Atrium): Score 3	Ability to Withdraw (Left Atrium): Score 4	Ability to Withdraw (Left Atrium): Score 5	Ability to Withdraw (Left Atrium): Score 6	Ability to Withdraw (Left Atrium): Score 7	Ability to Withdraw (Right Atrium): Score 1	Ability to Withdraw (Right Atrium): Score 2	Ability to Withdraw (Right Atrium): Score 3	Ability to Withdraw (Right Atrium): Score 4	Ability to Withdraw (Right Atrium): Score 5	Ability to Withdraw (Right Atrium): Score 6	Ability to Withdraw (Right Atrium): Score 7	Ability to Withdraw (Left Ventricle): Score 1	Ability to Withdraw (Left Ventricle): Score 2	Ability to Withdraw (Left Ventricle): Score 3	Ability to Withdraw (Left Ventricle): Score 4	Ability to Withdraw (Left Ventricle): Score 5	Ability to Withdraw (Left Ventricle): Score 6	Ability to Withdraw (Left Ventricle): Score 7	Ability to Withdraw (Right Ventricle): Score 1	Ability to Withdraw (Right Ventricle): Score 2	Ability to Withdraw (Right Ventricle): Score 3	Ability to Withdraw (Right Ventricle): Score 4	Ability to Withdraw (Right Ventricle): Score 5	Ability to Withdraw (Right Ventricle): Score 6	Ability to Withdraw (Right Ventricle): Score 7	Insertion/ Withdrawal from Introducer Sheath: Score 1	Insertion/ Withdrawal from Introducer Sheath: Score 2	Insertion/ Withdrawal from Introducer Sheath: Score 3	Insertion/ Withdrawal from Introducer Sheath: Score 4	Insertion/ Withdrawal from Introducer Sheath: Score 5	Insertion/ Withdrawal from Introducer Sheath: Score 6	Insertion/ Withdrawal from Introducer Sheath: Score 7	Learning Curve: Score 1	Learning Curve: Score 2	Learning Curve: Score 3	Learning Curve: Score 4	Learning Curve: Score 5	Learning Curve: Score 6	Learning Curve: Score 7
OPTRELL Mapping Catheter	0	0	0	0	0	6	17	0	0	0	0	0	3	3	0	0	0	3	1	5	0	0	0	0	1	0	0	0	0	0	0	0	7	7	9	0	0	0	0	1	1	4	0	0	0	5	0	4	0	0	0	1	0	0	0	0	0	0	0	2	3	12	6	0	0	0	0	2	1	3	0	0	1	3	2	3	0	0	0	0	1	0	0	0	0	0	0	0	0	8	15	0	0	0	0	0	4	2	0	0	0	2	2	5	0	0	0	0	0	0	1	0	0	0	1	2	9	9	10	0	0	0	4	4	18	5

Number of Responders for Physician Assessment for Pacing

Number of responders for physician assessment for pacing (local pacing capture) were reported. A post-procedure survey of 11 questions, each with individual sub-questions were asked. Each question/sub-question was answered by the physician using a Likert scale of 1 to 7 (1=poor and 7=excellent). Responders refers to participants with physician assessment for pacing. (NCT04983797)
Timeframe: Up to 72 days

Intervention	Participants (Count of Participants)
	Local pacing capture: Score 1	Local pacing capture: Score 2	Local pacing capture: Score 3	Local pacing capture: Score 4	Local pacing capture: Score 5	Local pacing capture: Score 6	Local pacing capture: Score 7
OPTRELL Mapping Catheter	0	0	1	1	2	2	3

Number of Responders for Physician Assessment for Signal Collection and Quality

Number of responders for physician assessment for signal collection and quality were reported. A post-procedure survey of 11 questions, each with individual sub-questions were asked. Each question/sub-question was answered by the physician using a Likert scale of 1 to 7 (1=poor and 7=excellent). Responders refers to participants with physician assessment for signal collection and quality (NCT04983797)
Timeframe: Up to 72 days

Intervention	Participants (Count of Participants)
	UNIPOLAR signals in Atrium: Score 1	UNIPOLAR signals in Atrium: Score 2	UNIPOLAR signals in Atrium: Score 3	UNIPOLAR signals in Atrium: Score 4	UNIPOLAR signals in Atrium: Score 5	UNIPOLAR signals in Atrium: Score 6	UNIPOLAR signals in Atrium: Score 7	UNIPOLAR signals in Ventricle: Score 1	UNIPOLAR signals in Ventricle: Score 2	UNIPOLAR signals in Ventricle: Score 3	UNIPOLAR signals in Ventricle: Score 4	UNIPOLAR signals in Ventricle: Score 5	UNIPOLAR signals in Ventricle: Score 6	UNIPOLAR signals in Ventricle: Score 7	UNIPOLAR noise encountered: Score 1	UNIPOLAR noise encountered: Score 2	UNIPOLAR noise encountered: Score 3	UNIPOLAR noise encountered: Score 4	UNIPOLAR noise encountered: Score 5	UNIPOLAR noise encountered: Score 6	UNIPOLAR noise encountered: Score 7	BIPOLAR signals in Atrium: Score 1	BIPOLAR signals in Atrium: Score 2	BIPOLAR signals in Atrium: Score 3	BIPOLAR signals in Atrium: Score 4	BIPOLAR signals in Atrium: Score 5	BIPOLAR signals in Atrium: Score 6	BIPOLAR signals in Atrium: Score 7	BIPOLAR signals in Ventricle: Score 1	BIPOLAR signals in Ventricle: Score 2	BIPOLAR signals in Ventricle: Score 3	BIPOLAR signals in Ventricle: Score 4	BIPOLAR signals in Ventricle: Score 5	BIPOLAR signals in Ventricle: Score 6	BIPOLAR signals in Ventricle: Score 7	BIPOLAR noise encountered: Score 1	BIPOLAR noise encountered: Score 2	BIPOLAR noise encountered: Score 3	BIPOLAR noise encountered: Score 4	BIPOLAR noise encountered: Score 5	BIPOLAR noise encountered: Score 6	BIPOLAR noise encountered: Score 7
OPTRELL Mapping Catheter	0	0	0	0	1	4	2	0	0	0	1	3	4	0	0	0	0	1	4	7	4	0	0	0	0	0	7	16	0	0	0	0	1	7	1	0	0	0	1	3	12	15

Number of Responders for Physician Assessment for Workflow

Number of responders for physician assessment for workflow were reported. A post-procedure survey of 11 questions, each with individual sub-questions were asked. Each question/sub-question was answered by the physician using a Likert scale of 1 to 7 (1=poor and 7=excellent). Responders refers to participants with physician assessment for workflow. (NCT04983797)
Timeframe: Up to 72 days

Intervention	Participants (Count of Participants)
	Ability to reduce fluoroscopy: Score 1	Ability to reduce fluoroscopy: Score 2	Ability to reduce fluoroscopy: Score 3	Ability to reduce fluoroscopy: Score 4	Ability to reduce fluoroscopy: Score 5	Ability to reduce fluoroscopy: Score 6	Ability to reduce fluoroscopy: Score 7	Time for pre-procedure mapping: Score 1	Time for pre-procedure mapping: Score 2	Time for pre-procedure mapping: Score 3	Time for pre-procedure mapping: Score 4	Time for pre-procedure mapping: Score 5	Time for pre-procedure mapping: Score 6	Time for pre-procedure mapping: Score 7	Time for post-procedure mapping after standard of care ablation: Score 1	Time for post-procedure mapping after standard of care ablation: Score 2	Time for post-procedure mapping after standard of care ablation: Score 3	Time for post-procedure mapping after standard of care ablation: Score 4	Time for post-procedure mapping after standard of care ablation: Score 5	Time for post-procedure mapping after standard of care ablation: Score 6	Time for post-procedure mapping after standard of care ablation: Score 7	Ability to identify targets: Score 1	Ability to identify targets: Score 2	Ability to identify targets: Score 3	Ability to identify targets: Score 4	Ability to identify targets: Score 5	Ability to identify targets: Score 6	Ability to identify targets: Score 7
OPTRELL Mapping Catheter	0	0	0	10	6	10	5	0	0	0	8	4	10	9	0	0	0	2	4	9	9	0	0	0	1	0	13	14

Reviews

3 reviews available for tetracaine and Drug Hypersensitivity

Article	Year
Toxicity of local anaesthetics. Best practice & research. Clinical anaesthesiology, 2003, Volume: 17, Issue:1 Topics: Anesthetics, Local; Animals; Bupivacaine; Cardiovascular System; Cocaine; Drug Hypersensitivity; Eti	2003
Toxicity of local anaesthetics. Best practice & research. Clinical anaesthesiology, 2003, Volume: 17, Issue:1 Topics: Anesthetics, Local; Animals; Bupivacaine; Cardiovascular System; Cocaine; Drug Hypersensitivity; Eti	2003
Toxicity of local anaesthetics. Best practice & research. Clinical anaesthesiology, 2003, Volume: 17, Issue:1 Topics: Anesthetics, Local; Animals; Bupivacaine; Cardiovascular System; Cocaine; Drug Hypersensitivity; Eti	2003
Toxicity of local anaesthetics. Best practice & research. Clinical anaesthesiology, 2003, Volume: 17, Issue:1 Topics: Anesthetics, Local; Animals; Bupivacaine; Cardiovascular System; Cocaine; Drug Hypersensitivity; Eti	2003
Toxicity of local anaesthetics. Best practice & research. Clinical anaesthesiology, 2003, Volume: 17, Issue:1 Topics: Anesthetics, Local; Animals; Bupivacaine; Cardiovascular System; Cocaine; Drug Hypersensitivity; Eti	2003
Toxicity of local anaesthetics. Best practice & research. Clinical anaesthesiology, 2003, Volume: 17, Issue:1 Topics: Anesthetics, Local; Animals; Bupivacaine; Cardiovascular System; Cocaine; Drug Hypersensitivity; Eti	2003
Toxicity of local anaesthetics. Best practice & research. Clinical anaesthesiology, 2003, Volume: 17, Issue:1 Topics: Anesthetics, Local; Animals; Bupivacaine; Cardiovascular System; Cocaine; Drug Hypersensitivity; Eti	2003
Toxicity of local anaesthetics. Best practice & research. Clinical anaesthesiology, 2003, Volume: 17, Issue:1 Topics: Anesthetics, Local; Animals; Bupivacaine; Cardiovascular System; Cocaine; Drug Hypersensitivity; Eti	2003
Toxicity of local anaesthetics. Best practice & research. Clinical anaesthesiology, 2003, Volume: 17, Issue:1 Topics: Anesthetics, Local; Animals; Bupivacaine; Cardiovascular System; Cocaine; Drug Hypersensitivity; Eti	2003
Local anesthesia. 1. The New England journal of medicine, 1972, May-04, Volume: 286, Issue:18 Topics: Action Potentials; Anesthesia, Local; Anesthetics, Local; Animals; Cardiovascular System; Cell Membr	1972
[N-(gamma-(4-phenoxymethylphenyl)propyl)-morpholine--a new surface anesthetic of remarkable tolerance. 6. Report on the syntheses of new compounds with local anethetic effect. 1]. Arzneimittel-Forschung, 1968, Volume: 18, Issue:6 Topics: Anesthetics, Local; Animals; Anti-Inflammatory Agents; Autonomic Nervous System; Bacteria; Blood Pre	1968

Other Studies

17 other studies available for tetracaine and Drug Hypersensitivity

Article	Year
Allergic contact dermatitis caused by tetracaine contained in otic drops. Contact dermatitis, 2011, Volume: 65, Issue:3 Topics: Aged, 80 and over; Allergens; Anesthetics, Local; Dermatitis, Allergic Contact; Drug Hypersensitivit	2011
[BRONCHOSCOPY. COMPLICATIONS]. El Dia medico, 1963, Jul-15, Volume: 35 Topics: Bronchial Diseases; Bronchoscopy; Drug Hypersensitivity; Postoperative Complications; Tetracaine; To	1963
Hypersensitivity to procaine, tetracaine, mepivacaine, and methylparaben: report of a case. Journal of the American Dental Association (1939), 1983, Volume: 106, Issue:1 Topics: Anesthesia, Dental; Anesthetics, Local; Drug Hypersensitivity; Female; Humans; Mepivacaine; Middle A	1983
Cholinesterase deficiency. Anaesthesia and intensive care, 1983, Volume: 11, Issue:1 Topics: Anesthetics; Anesthetics, Local; Cholinesterases; Drug Hypersensitivity; Humans; Procaine; Propanidi	1983
Adverse reactions to topical ocular anesthetics. Journal of the American Optometric Association, 1976, Volume: 47, Issue:6 Topics: Administration, Topical; Anesthetics; Anesthetics, Local; Cocaine; Cornea; Drug Hypersensitivity; Ed	1976
Chemical, pharmaceutical and clinical standardization of the TRUE Test caine mix. Contact dermatitis, 1989, Volume: 21, Issue:1 Topics: Adult; Aged; Benzocaine; Cellulose; Chromatography, High Pressure Liquid; Dibucaine; Drug Hypersensi	1989
Benzocaine--an unsatisfactory indicator of topical local anaesthetic sensitization for the U.K. The British journal of dermatology, 1988, Volume: 118, Issue:1 Topics: Benzocaine; Dibucaine; Drug Hypersensitivity; Humans; Patch Tests; Retrospective Studies; Tetracaine	1988
[Complications of regional anaesthesia and their treatment (author's transl)]. Munchener medizinische Wochenschrift (1950), 1973, Oct-12, Volume: 115, Issue:41 Topics: Adrenal Cortex Hormones; Anesthesia, Local; Apnea; Barbiturates; Bradycardia; Bupivacaine; Diagnosis	1973
Local anesthetic reactions: prevention, diagnosis, treatment. Journal of the South Carolina Medical Association (1975), 1974, Volume: 70, Issue:11 Topics: Aged; Anesthesia, Local; Drug Hypersensitivity; Female; Humans; Lidocaine; Male; Middle Aged; Tetrac	1974
[Iatrogenic lesion in ophthalmologic anesthesia]. Klinische Monatsblatter fur Augenheilkunde, 1972, Volume: 161, Issue:3 Topics: Adult; Aged; Anesthesia, General; Anesthesia, Local; Anesthetics; Anesthetics, Local; Atropine; Blin	1972
Corticosteroid allergy in a patient with systemic lupus erythematosus. The Johns Hopkins medical journal, 1974, Volume: 134, Issue:6 Topics: Adrenal Cortex Hormones; Arthritis; Biopsy; Conjunctivitis; Dermatitis; Dexamethasone; DNA; Drug Hyp	1974
A comparison of dermal sensitivity to preservative and local anesthetic drugs. Annals of allergy, 1971, Volume: 29, Issue:9 Topics: Anesthetics, Local; Benzocaine; Drug Hypersensitivity; Humans; Hypersensitivity, Delayed; Hypersensi	1971
Evaluation of patients with history of allergy to local anesthetic drugs. Southern medical journal, 1971, Volume: 64, Issue:9 Topics: Adolescent; Adult; Aged; Anesthetics, Local; Child; Drug Hypersensitivity; Female; Humans; Lidocaine	1971
[Intermittent macroglossia]. Deutsche medizinische Wochenschrift (1946), 1970, Dec-04, Volume: 95, Issue:49 Topics: Diagnosis, Differential; Drug Hypersensitivity; Edema; Glossitis; Humans; Male; Middle Aged; Tetraca	1970
[A case of clinical death caused by dicaine sensitivity]. Khirurgiia, 1970, Volume: 23, Issue:5 Topics: Acute Kidney Injury; Adult; Anesthesia; Drug Hypersensitivity; Humans; Male; Tetracaine	1970
[On a fatal outcome in dicaine anesthesia]. Vrachebnoe delo, 1967, Volume: 5 Topics: Anesthesia, Local; Drug Hypersensitivity; Humans; Male; Middle Aged; Tetracaine	1967
Ocular sensitivity of dogs to topical tetracaine HCl. Journal of the American Veterinary Medical Association, 1969, Jan-01, Volume: 154, Issue:1 Topics: Animals; Conjunctivitis; Dog Diseases; Dogs; Drug Hypersensitivity; Ophthalmic Solutions; Tetracaine	1969